A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma

NCT02561962 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen